HOOKIPA Pharma Inc.

NASDAQ: HOOK · Real-Time Price · USD
0.83
-0.01 (-1.19%)
At close: Aug 15, 2025, 1:55 PM

HOOKIPA Pharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
43.95M 20.13M 14.25M 18.45M
Cost of Revenue
n/a 3.55M 3.6M 4.64M
Gross Profit
43.95M 16.58M 10.65M 13.81M
Operating Income
-51.45M -97.69M -73.16M -81.67M
Interest Income
3.7M 5.29M 1.63M 27K
Pretax Income
-43.61M -81.21M -64.92M -75.67M
Net Income
-43.5M -81.58M -64.92M -75.67M
Selling & General & Admin
20.23M 18.63M 18.76M 17.27M
Research & Development
68.51M 86.42M 68.64M 82.85M
Other Expenses
6.67M 12.77M -392K -2.84M
Operating Expenses
95.4M 117.82M 87.4M 100.12M
Interest Expense
2K 317K 687K 898K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
95.4M 117.82M 87.4M 100.12M
Income Tax Expense
-106K 368K 230K 1K
Shares Outstanding (Basic)
12.54M 9.45M 6.55M 3.28M
Shares Outstanding (Diluted)
12.54M 9.45M 6.55M 3.28M
EPS (Basic)
-3.47 -8.63 -9.91 -23.04
EPS (Diluted)
-3.47 -8.63 -9.91 -23.04
EBITDA
-40.85M -77.34M -60.4M -70.13M
EBIT
-43.61M -80.89M -64M -74.77M
Depreciation & Amortization
2.75M 3.55M 3.6M 4.64M